ALEXANDRIA, LA / ACCESSWIRE / July 22, 2014 / Oncologix Tech Inc. (OTC PINK: OCLG) (PINKSHEETS: OCLG), a fully reporting, diversified medical holding company with operating business units in medical device, healthcare services and medical products and technologies, has agreed to terms with Mr. Harold Halman, to serve as the President/COO of the newly formed Medical Products and Technology Division.
Mr. Halman brings 20+ years of new business development, medical sales, marketing and operations experience to OCLG. Prior to joining the company, Harold was the Chief Executive Officer for Global Medical located in Phoenix, Arizona, a national provider for home medical equipment. Mr Halman has vast knowledge and direct industry experience in medical devices and home medical products that will accelerate expansion within the company’s Medical Products and Technology Division both domestically and internationally. Prior to Global Medical, Mr. Halman was CEO of his management consulting firm involved in M&A, business turnarounds and business development projects. His direct experience includes bringing forth breakthrough medical products and technologies to the market with aggressive, multi-tiered distribution strategies.
"We are extremely pleased to have Harold join our management team" said Wayne Erwin, Chairman and CEO. "He has the industry experience we need in managing HME/DME providers, extensive manufacturer relationships, and we are confident that Harold will successfully drive new business growth for our new Medical Product Division".
Harold Halman resides in Phoenix, Arizona with his wife and two daughters.
About Oncologix Tech
Oncologix is a diversified medical holding company that operates and manufactures Class II medical device products, delivers Personal Healthcare Services, and provides sales and distribution of medical products and technologies. For its clients, Oncologix provides FDA approved medical devices, state licensed healthcare services, and medical products and technologies. For its shareholders, Oncologix operates profitable business divisions that build, maintain and nourish shareholder value. The Company’s corporate mission is to be the best small cap medical device and healthcare services holding company in North America.
Forward-Looking Statements:
This press release may contain forward-looking statements, made in reliance upon Section 21D of the Exchange Act of 1934, which involve known and unknown risks, uncertainties or other factors that could cause actual results to differ materially from the results, performance, or expectations implied by these forward-looking statements. The Company's expectations, among other things, are dependent upon economic conditions, continued demand for its products, the availability of raw materials, retention of its key management and operating personnel, its ability to operate its subsidiary companies effectively, need for and availability of more capital as well as other uncontrollable or unknown factors which are more fully disclosed in the Company's filings with the Securities and Exchange Commission.
Contact:
Oncologix Tech Inc.
Wayne Erwin, Chairman and CEO
(318) 451-9543
Investor Relations
Synergy:
(888) 259- 9173
SOURCE: Oncologix Tech Inc.